Evidence map›Paper›PMID 40861331›Full record

ArticleSurgical case reports2025

Anaplastic Sarcoma of the Kidney in a Child with

Eri Nagasaki-Maeoka, Katsuyoshi Shimozawa, Masaru Ueno, Kanako Saiki, Hiroshi Yagasaki, Haruna Nishimaki-Watanabe, Ryusuke Tsujimura, Yoshiko Nakano, Motohiro Kato, Tsugumichi Koshinaga and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eri Nagasaki-MaeokaDepartment of Pediatric Surgery, Nihon University School of Medicine, Tokyo, Japan.
Katsuyoshi ShimozawaDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Masaru UenoDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Kanako SaikiDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Hiroshi YagasakiDepartment of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Haruna Nishimaki-WatanabeDivision of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Ryusuke TsujimuraDivision of Human Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Yoshiko NakanoDepartment of Pediatrics, the University of Tokyo, Tokyo, Japan.
Motohiro KatoDepartment of Pediatrics, the University of Tokyo, Tokyo, Japan.
Tsugumichi KoshinagaDepartment of Pediatric Surgery, Nihon University School of Medicine, Tokyo, Japan.
Shuichiro UeharaDepartment of Pediatric Surgery, Nihon University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnaplastic sarcoma of the kidney (ASK) is a rare renal tumor, with fewer than 50 cases reported in the literature since 2007. ASK is pathologically characterized by the presence of cystic and solid areas consisting of spindle cells showing marked anaplasia. Recent studies have reported that the vast majority of patients with ASK have CASE PRESENTATION: A previously healthy 2-year-old girl presented with gross hematuria and a mass in her right abdomen. She had a family history of tumor; her eldest maternal aunt had developed rhabdomyosarcoma, another maternal aunt had follicular thyroid cancer, and her maternal grandmother had a benign thyroid tumor. Imaging revealed a 10-cm tumor with conspicuous internal cystic structures in the right kidney. The patient underwent right nephrectomy, removing a tumor measuring 12.5 × 9 × 8 cm that contained cystic and solid parts. The tumor was composed of spindle-shaped cells with anaplastic changes. Finally, the diagnosis of ASK was established. The treatment regimen, in accordance with the therapy for clear cell sarcoma of the kidney or diffuse anaplasia type Wilms tumor, was administered. Based on the diagnosis of ASK and the family history of

conclusionsTreatment with intensive chemotherapy (vincristine, doxorubicin, etoposide, and cyclophosphamide) and abdominal irradiation was effective as 2-year event-free survival was achieved. Since

Indexed as

anaplastic sarcoma of the kidneychildrenDICER1rare renal tumor

Identifiers

PMID40861331
PMCPMC12375878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.